Javascript must be enabled to continue!
Comparative Analysis of Cardiovascular Disease risk in a local population of Sri Lankans using risk predictors: WHO ISH charts, Original and recalibrated Framingham Equation
View through CrossRef
Abstract
Background: Cardiovascular diseases (CVDs) accounted for 32% of global deaths in 2019, mostly in lower and middle-income countries and ischemic heart diseases and stroke were leading causes. Prevention relies on individual CVD risk prediction using methods like the Framingham Risk Equation, SCORE, and WHO ISH charts for effective screening and management.This study focuses on assessing and comparing CVD risk using different WHO ISH charts and both traditional and recalibrated Framingham equations and calculating the agreement between specific risk predictors.
Methods:CVD risk was assessed using WHO ISH Chart with cholesterol levels of 5mmol/dl and 4mmol/dl, and individual cholesterol levels. Additionally, the non-cholesterol WHO ISH Chart was used. The four values were compared using the Cohen Kappa statistic. CVD risk was calculated using the traditional Framingham Equation and a recalibrated version with local data. These were compared with WHO ISH Chart results using Cohen Kappa statistic. The Framingham scores were categorized per WHO ISH categories. Multivariate analysis was performed using SPSS 25 to find out the association between risk factors not used for risk calculation with the predicted cardiovascular disease risk.
Results:WHO ISH methods indicated a 10-year CVD risk below 10% for over 90% of the population. Original and recalibrated Framingham scores predicted 55.5% and 62.3% with less than 10% risk, respectively. Significant gender differences were noted in high CVD risk category between the original Framingham (13.8% females vs. 21.3% males) and recalibrated Framingham (9% females vs. 13.4% males) risk equation. WHO ISH cholesterol method showed substantial agreement (k=0.716, p<0.001) with WHO ISH assume 5 method, while the non-cholesterol method had slight agreement (k=0.124, p<0.01) with WHO ISH assume 4 method. Substantial agreement (k=0.613, p<0.01) was found between original and recalibrated Framingham scores. The original Framingham score had poor agreement with WHO ISH methods, but recalibration improved the values, with the highest being fair agreement (k=0.365, p<0.01) with the WHO ISH cholesterol method.
Conclusion:Different CVD risk prediction methods yielded varying 10-year risk distributions. Significant differences were observed between original and recalibrated Framingham scores. Varying levels of agreement were observed between risk predictors. Associations were also found between non-calculated risk factors and predicted CVD risk.
Springer Science and Business Media LLC
Title: Comparative Analysis of Cardiovascular Disease risk in a local population of Sri Lankans using risk predictors: WHO ISH charts, Original and recalibrated Framingham Equation
Description:
Abstract
Background: Cardiovascular diseases (CVDs) accounted for 32% of global deaths in 2019, mostly in lower and middle-income countries and ischemic heart diseases and stroke were leading causes.
Prevention relies on individual CVD risk prediction using methods like the Framingham Risk Equation, SCORE, and WHO ISH charts for effective screening and management.
This study focuses on assessing and comparing CVD risk using different WHO ISH charts and both traditional and recalibrated Framingham equations and calculating the agreement between specific risk predictors.
Methods:CVD risk was assessed using WHO ISH Chart with cholesterol levels of 5mmol/dl and 4mmol/dl, and individual cholesterol levels.
Additionally, the non-cholesterol WHO ISH Chart was used.
The four values were compared using the Cohen Kappa statistic.
CVD risk was calculated using the traditional Framingham Equation and a recalibrated version with local data.
These were compared with WHO ISH Chart results using Cohen Kappa statistic.
The Framingham scores were categorized per WHO ISH categories.
Multivariate analysis was performed using SPSS 25 to find out the association between risk factors not used for risk calculation with the predicted cardiovascular disease risk.
Results:WHO ISH methods indicated a 10-year CVD risk below 10% for over 90% of the population.
Original and recalibrated Framingham scores predicted 55.
5% and 62.
3% with less than 10% risk, respectively.
Significant gender differences were noted in high CVD risk category between the original Framingham (13.
8% females vs.
21.
3% males) and recalibrated Framingham (9% females vs.
13.
4% males) risk equation.
WHO ISH cholesterol method showed substantial agreement (k=0.
716, p<0.
001) with WHO ISH assume 5 method, while the non-cholesterol method had slight agreement (k=0.
124, p<0.
01) with WHO ISH assume 4 method.
Substantial agreement (k=0.
613, p<0.
01) was found between original and recalibrated Framingham scores.
The original Framingham score had poor agreement with WHO ISH methods, but recalibration improved the values, with the highest being fair agreement (k=0.
365, p<0.
01) with the WHO ISH cholesterol method.
Conclusion:Different CVD risk prediction methods yielded varying 10-year risk distributions.
Significant differences were observed between original and recalibrated Framingham scores.
Varying levels of agreement were observed between risk predictors.
Associations were also found between non-calculated risk factors and predicted CVD risk.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Recalibration of Framingham risk for a local population of Sri Lanka
Recalibration of Framingham risk for a local population of Sri Lanka
Abstract
Background
Cardiovascular Diseases (CVD) account for the highest number of deaths and disability globally and wi...
Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score – A prospective study
Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score – A prospective study
Objective
Despite the fact that cancer and heart diseases are interconnected, there is lack of information about the prevalence of cardiovascular risk in cancer...
Cardiovascular Risk Assessment among Adults in Primary Health Care Settings in Sulaimani Using WHO Risk Prediction Charts
Cardiovascular Risk Assessment among Adults in Primary Health Care Settings in Sulaimani Using WHO Risk Prediction Charts
WHO adopted World Health Organization/International Society of Hypertension (WHO/ISH) risk charts to predict cardiovascular disease risk in low and middle income countries. The aim...
Recalibration of Framingham Risk for a local population of Sri Lanka
Recalibration of Framingham Risk for a local population of Sri Lanka
Abstract
Background
Cardiovascular Diseases (CVD) account for highest number of deaths and disability globally and within Sri Lanka. A CVD risk prediction tool is a simple ...
Estimation of the cardiovascular risk using world health organization/international society of hypertension risk prediction charts in Central Vietnam
Estimation of the cardiovascular risk using world health organization/international society of hypertension risk prediction charts in Central Vietnam
Introduction
Cardiovascular disease (CVD) being the leading cause of the morbidity and mortality in Vietnam, the objective of this study was to estimate the total 10-year CVD risk ...
Pathological Response to Herceptin-containing Neoadjuvant Therapy in HER2 IHC2+/ISH+ and IHC3+ Early-Stage Invasive Ductal Carcinoma
Pathological Response to Herceptin-containing Neoadjuvant Therapy in HER2 IHC2+/ISH+ and IHC3+ Early-Stage Invasive Ductal Carcinoma
ABSTRACTBackground:HER2-positive breast cancers exhibit heterogeneous responses to neoadjuvant therapy. This study compared pathologic response between IHC 3+ and IHC 2+/ISH+ invas...

